1. Strathdee SA, Van Ameijden E, Mesquita F, Wodak A, Rana S, Vlahov D. Can HIV epidemics among injection drug users be prevented? AIDS. 1998;12(A):71–9.
2. Noroozi M, Mirzazadeh A, Noroozi A, Mehrabi Y, Hajebi A, Zamani S, et al. Client-level coverage of needle and syringe program and high-risk injection behaviors: a case study of people who inject drugs in Kermanshah, Iran. Addiction and Health. 2015;7:3–4.
3. Maher L, Jalaludin B, Chant K, Kaldor J. Hepatitis C among intravenous drug users. Epidemiology. 2005;16(3):423.
4. Lowndes CM, Alary M, Platt L. Injection drug use, commercial sex work, and the HIV/STI epidemic in the Russian Federation. Sex Transm Dis. 2003;30(1):46–8.
5. Mirahmadizadeh A, Majdzadeh R, Mohammad K, Forouzanfar M. Prevalence of HIV and hepatitis C virus infections and related behavioral determinants among injecting drug users of drop-in centers in Iran. Iranian Red Crescent Medical Journal. 2009;11(3):325.